Dr. Susan D’Costa is a molecular virologist with over 25 years of experience, including more than a decade in viral vector gene therapy. Her expertise spans viral vector analytics, process development, manufacturing, and team building. She currently serves on the board of Elly’s Team and on the Scientific Advisory Board for Precision Biosciences. Before joining Genezen, Susan was CTO at Alcyone Therapeutics, leading viral vector CMC, device development, and technology partnerships. She has also held senior roles at Thermo Fisher Scientific’s Viral Vector Services, Brammer Bio, and Florida Biologix, supporting a range of viral vector platforms and biotech clients. Susan holds a Ph.D. in molecular virology from Texas Tech University, an M.S. in biochemistry from Mumbai University (Grant Medical College), and a B.S. in microbiology/biochemistry from St. Xavier’s College, Mumbai.
